Characterization of a New Enterococcal Gene, satG , Encoding a Putative Acetyltransferase Conferring Resistance to Streptogramin A Compounds
Year: 1999
Type: article
Abstract: Streptogramin antibiotics are mixtures of two chemically unrelated A and B compounds that act synergistically in vivo against gram-positive pathogens, such as staphylococci, streptococci, and enterococci (8, 11). Resistance against B compounds is very widespread among enterococci and is mediated via the ermBgene cluster (e.g., on Tn917) that confers macrolide-lincosamide-streptogramin B resistance (7). The synergistic mixture of streptogramins A and B overcomes resistance to B compounds but is inactive in resistance to A compounds. The only known resistance mechanism against streptogramin A compounds in enterococci is mediated by the streptogramin acetyltransferase SatA (9). Enterococcus faecium isolates withsatA-mediated resistance have been found in samples of human and animal origins, indicating a possible spread of resistance genes or resistant bacteria among different ecosystems (10).Fig. 1.A 904-bp sequence located on the 5.5-kbp cloned fragment in pUC18 (GenBank accession no. AF139725). The ORF begins at nucleotide 63 with an ATG start codon preceding a putative ribosomal binding site (RBS) (double-underlined) at positions 50 to 57. The predicted gene sequence encodes a protein of 214 aa which shows significant homology with other streptogramin acetyltransferases (aa motifs I, II, III; see also Fig. 2). The locations of the primers satG1 and satG2, specific only for the satG sequence, are underlined (plus strand).
Authors: G. Werner, W. Witte
Institution: Robert Koch Institute
Language: English
Subfield: Microbiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1540026877
